NCT07303114 Missed Opportunities for HIV Screening in General Practice
| NCT ID | NCT07303114 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | HIV Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-14 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-04-14 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The number of new HIV diagnoses in France in 2022 is estimated to be between 4,200 and 5,700. Of these diagnoses, 43% of infections were detected at a late stage. The objective of this study is to identify missed opportunities for HIV testing in general practice and to understand the barriers to testing.
Eligibility Criteria
Inclusion Criteria: * Adult subject (≥18 years) * diagnosed with HIV infection between January 1, 2021, and July 30, 2024 Exclusion Criteria: -Subject who arrived in France in the year preceding or during the period between January 1, 2024, and July 30, 2024.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07303114 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07303114 currently recruiting?
Yes, NCT07303114 is actively recruiting participants. Contact the research team at baptiste.hoellinger@chru-strasbourg.fr for enrollment information.
Where is the NCT07303114 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07303114 clinical trial?
NCT07303114 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.